Thorsten Graef

An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Endpoints
Tue, 05/11/21 - 11:10 am
Thorsten Graef
Pharmacyclics
AbbVie
oncology
Acepodia
NK cells